Used in research as a selective antagonist for the GPR55 receptor, IMR-1 helps investigate signaling pathways involved in inflammation, pain, and cancer progression. It is valued for its ability to modulate cellular responses in studies exploring immune regulation and tumor growth. Due to its specificity, it serves as a tool compound in drug discovery, particularly for developing therapies targeting metabolic and inflammatory diseases.